Hysteroscopy Procedures Market

The global hysteroscopy procedures market accounted for USD 4.61 billion in 2023 and is expected to reach at USD 10.17 billion by 2034 with a CAGR of 7.46% during the forecast period 2024-2034. Increased investments and favorable reimbursement policies, a shift toward minimally invasive surgeries (MIS), growing awareness and technological advancements, rising prevalence of gynecological disorders, and strategic alliances and collaborations will all contribute to the market's growth.

The need for hysteroscopy treatments is being driven by the increasing occurrence of gynecological problems, including fibroids, polyps, abnormal uterine bleeding, endometrial hyperplasia, and infertility. A growing number of women choose hysteroscopy for diagnosis and treatment as knowledge about these illnesses increases and diagnostic tools advance. For instance, in January 2022, Olympus announced the release of the VISERA ELITE II surgical video system, which improves visualization capabilities in minimally invasive surgeries.

By procedure, the CPT code 58558 segment accounted for the highest revenue-grossing segment in the global hysteroscopy procedures market in 2023 owing to the widespread adoption of minimally invasive surgical techniques, increasing prevalence of gynecological disorders such as fibroids and polyps, advancements in hysteroscopic technology, and rising demand for outpatient procedures due to shorter recovery times and reduced hospital stays. For instance, in January 2022, Boston Scientific expanded their neuromodulation portfolio with the FDA's 510(k) clearance for the VerciseTM GenusTM Deep Brain Stimulation System. Additionally, the CPT code 58353 segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing trend towards office-based hysteroscopy procedures, advancements in hysteroscopic instrumentation enabling easier and more efficient diagnostic procedures, growing awareness about early detection of gynecological conditions, and rising demand for minimally invasive treatment options with reduced patient discomfort and faster recovery times.

By end-user, the hospital's segment accounted for the highest revenue-grossing segment in the global hysteroscopy procedures market in 2023 owing to the availability of advanced infrastructure and equipment for complex procedures, a higher number of inpatient surgeries, established referral networks, and greater trust among patients for hospital-based care, especially for operative hysteroscopy requiring specialized facilities and skilled medical professionals. For instance, Cook Medical announced the opening of the UROLOGYPCNL.COM website in January 2022, providing information and assistance for percutaneous nephrolithotomy operations. Additionally, the ambulatory surgical centers segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing shift towards outpatient procedures, rising demand for cost-effective healthcare solutions, advancements in technology allowing for more complex procedures to be performed in ambulatory settings, and initiatives by governments and healthcare providers to promote day surgery and reduce hospitalization rates.

North American region is anticipated to have the highest revenue share during the forecast period owing to the presence of well-established healthcare infrastructure, high adoption rates of advanced medical technologies, increasing prevalence of gynecological disorders, favorable reimbursement policies, and rising awareness about women's health issues, driving demand for hysteroscopy procedures. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rapidly expanding healthcare infrastructure, increasing healthcare expenditure, rising awareness about women's health issues, improving access to healthcare services, growing prevalence of gynecological disorders, and advancements in medical technology, driving the demand for hysteroscopy procedures in the region. For instance, in June 2022, UroViu unveiled the FDA-510k cleared Hystero-V single-use hysteroscopy. This device has three procedure-augmented single-use cystoscopes and one reusable handle. It is compatible with their Always Ready endoscopy platform.

This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.

Report Scope:

• Base Year: 2023
• Forecast Period: 2024-2034
• Study Coverage
• Market Forecast by Procedure, and End-User
• Market Forecast for 5 Regions and 17+ Countries
• North America (U.S. and Canada)
• Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
• Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
• Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
• MEA (South Africa, GCC, Rest of MEA)
• Exhaustive Company Profiles of the Top 10+ Major Market Players

Segmentation: Hysteroscopy Procedures Market Report 2023 - 2034

Hysteroscopy Procedures Market Analysis & Forecast by Procedure 2023 - 2034 (Revenue USD Bn)

• CPT code 58555
• CPT code 58558
• CPT code 58562
• CPT code 58340
• CPT code 58563
• CPT code 58565
• CPT code 58353
• CPT code 58561
• Others

Hysteroscopy Procedures Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)

• Hospitals
• Ambulatory Surgery Centers
• Clinics
• Others

Hysteroscopy Procedures Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• UK
• Spain
• Italy
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Rest of LATAM
• Middle East & Africa
• South Africa
• GCC
• Rest of MEA